David R. Shook's most recent trade in Lyell Immunopharma Inc was a trade of 1,977 Common Stock done at an average price of $12.6 . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 10 Jun 2026 | 1,977 | 20,923 | - | 12.6 | 24,989 | Common Stock |
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 50,000 | 50,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 43,750 | 43,750 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | David R. Shook | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 21,900 | 21,900 | - | 0 | Common Stock | |
| Nkarta Inc | David R. Shook | See Remarks | 15 Jan 2025 | 8,638 | 190,955 | - | 2.2 | 19,004 | Common Stock | |
| Nkarta Inc | David R. Shook | See Remarks | 03 Jan 2025 | 117,500 | 117,500 | - | - | Stock Option (right to buy) | ||
| Nkarta Inc | David R. Shook | See Remarks | 03 Jan 2025 | 59,000 | 199,593 | - | 0 | Common Stock | ||
| Nkarta Inc | David R. Shook | See Remarks | 21 Aug 2024 | 1,352 | 138,593 | - | 5.1 | 6,909 | Common Stock | |
| Nkarta Inc | David R. Shook | See Remarks | 15 Jul 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | ||
| Nkarta Inc | David R. Shook | See Remarks | 15 Jul 2024 | 23,421 | 139,945 | - | 0 | Common Stock |